Growth Metrics

ENDRA Life Sciences (NDRA) Shares Outstanding (Weighted Average) (2016 - 2021)

Historic Shares Outstanding (Weighted Average) for ENDRA Life Sciences (NDRA) over the last 6 years, with Q3 2021 value amounting to $41.9 million.

  • ENDRA Life Sciences' Shares Outstanding (Weighted Average) rose 7544.27% to $41.9 million in Q3 2021 from the same period last year, while for Sep 2021 it was $41.9 million, marking a year-over-year increase of 7544.27%. This contributed to the annual value of $19.2 million for FY2020, which is 15589.69% up from last year.
  • ENDRA Life Sciences' Shares Outstanding (Weighted Average) amounted to $41.9 million in Q3 2021, which was up 7544.27% from $41.7 million recorded in Q2 2021.
  • In the past 5 years, ENDRA Life Sciences' Shares Outstanding (Weighted Average) registered a high of $41.9 million during Q3 2021, and its lowest value of $723335.0 during Q1 2017.
  • For the 5-year period, ENDRA Life Sciences' Shares Outstanding (Weighted Average) averaged around $13.0 million, with its median value being $7.4 million (2019).
  • As far as peak fluctuations go, ENDRA Life Sciences' Shares Outstanding (Weighted Average) changed by 0.0% in 2017, and later soared by 44235.27% in 2018.
  • Quarter analysis of 5 years shows ENDRA Life Sciences' Shares Outstanding (Weighted Average) stood at $2.8 million in 2017, then surged by 63.4% to $4.5 million in 2018, then soared by 66.49% to $7.5 million in 2019, then surged by 155.9% to $19.2 million in 2020, then skyrocketed by 118.38% to $41.9 million in 2021.
  • Its last three reported values are $41.9 million in Q3 2021, $41.7 million for Q2 2021, and $37.8 million during Q1 2021.